Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Scand J Clin Lab Invest ; 63(7-8): 497-503, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14743959

RESUMEN

In this study the relation between lysophosphatidic acid (LPA) and myocardial infarction was investigated, the typical and simplified methods for measuring serum LPA concentration by dot immunogold filtration assay (DIFA) based on a polyclonal antibody to LPA were developed, and serum LPA concentrations were measured in 31 patients with acute myocardial infarction (AMI) and 12 controls (blood donors) by DIFA. Serum LPA levels were raised more than twofold 8 h after the onset of AMI. Maximal elevation (10.43 mg/L) was found at 48-72 h following onset and remained higher than the control concentration (1.66 mg/L) 7 days after AMI. The rise in serum LPA concentration in AMI patients suggests that LPA might be involved in AMI-related pathophysiology in the cardiovascular system. The simplified DIFA developed in the present study for measuring serum LPA concentration is convenient and highly sensitive.


Asunto(s)
Lisofosfolípidos/sangre , Infarto del Miocardio/sangre , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos/inmunología , Especificidad de Anticuerpos/inmunología , Unión Competitiva/inmunología , Biomarcadores/sangre , Creatina Quinasa/sangre , Femenino , Humanos , Inmunoensayo/métodos , Isoenzimas/sangre , L-Lactato Deshidrogenasa/sangre , Lisofosfolípidos/inmunología , Masculino , Persona de Mediana Edad , Factores de Tiempo , Troponina T/sangre
2.
Bioorg Med Chem Lett ; 10(15): 1691-3, 2000 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-10937726

RESUMEN

By using colloidal gold as a hapten carrier, a kind of antibody against lysophosphatidic acid (LPA) was developed and used to successfully detect 500 ng/mL LPA in dot immunogold filtration assay. Such application of the LPA antibody could offer us a way to diagnose ovarian cancer at its early stage.


Asunto(s)
Anticuerpos/aislamiento & purificación , Lisofosfolípidos/inmunología , Anticuerpos/química , Anticuerpos/inmunología , Especificidad de Anticuerpos , Femenino , Humanos , Sueros Inmunes , Neoplasias Ováricas/diagnóstico
3.
Oncogene ; 19(11): 1419-27, 2000 Mar 09.
Artículo en Inglés | MEDLINE | ID: mdl-10723133

RESUMEN

Gene amplification is frequently present in human tumors, although specific target genes relevant to many amplified loci remain unidentified. An expression cloning assay enabled identification of a candidate oncogene derived from human chromosome 3p14.1. The cDNA retrieved from morphologically transformed cells contained the full-length protein coding region and detected an abundant transcript in the same cells. Sequence analysis revealed identity with the wild-type sequence of p44S10, a highly conserved subunit of the 26S proteasome that exhibits similarity to the Arabidopsis fus6/cop11 family of signaling molecules. p44S10 gene copy number and mRNA expression were increased in association with segmental 1.8 - 11-fold chromosomal gains in cutaneous malignant melanoma cell lines (5/13; 40%) and tumors (2/40; 5%), and in breast cancer MCF-7 cells. Likewise, malignant progression of human radial growth phase WM35 melanoma cells was associated with amplification and increased expression of endogenous p44S10, and increased expression of p44S10 was sufficient to induce proliferation of WM35 cells in vivo. The results demonstrate segmental copy number gains within chromosome 3p in cutaneous malignant melanoma and suggest that deregulation of a proteasome regulatory particle subunit may contribute to the malignant phenotype.


Asunto(s)
Adenosina Trifosfatasas/genética , Cisteína Endopeptidasas/genética , Amplificación de Genes , Melanoma/enzimología , Melanoma/genética , Complejos Multienzimáticos/genética , Proteínas Oncogénicas/genética , Neoplasias Cutáneas/enzimología , Neoplasias Cutáneas/genética , Adenosina Trifosfatasas/aislamiento & purificación , Animales , Línea Celular Transformada , Cromosomas Humanos Par 17 , Cromosomas Humanos Par 20 , Cromosomas Humanos Par 3 , Cisteína Endopeptidasas/aislamiento & purificación , Cisteína Endopeptidasas/metabolismo , Progresión de la Enfermedad , Activación Enzimática/genética , Humanos , Melanoma/patología , Melanoma Experimental/enzimología , Melanoma Experimental/genética , Melanoma Experimental/patología , Ratones , Ratones Desnudos , Datos de Secuencia Molecular , Complejos Multienzimáticos/aislamiento & purificación , Complejos Multienzimáticos/metabolismo , Proteínas Oncogénicas/aislamiento & purificación , Proteínas Oncogénicas/metabolismo , Péptido Hidrolasas/genética , Péptido Hidrolasas/aislamiento & purificación , Péptido Hidrolasas/metabolismo , Complejo de la Endopetidasa Proteasomal , Ratas , Análisis de Secuencia de ADN , Neoplasias Cutáneas/patología , Células Tumorales Cultivadas
4.
Panminerva Med ; 41(4): 331-4, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10705715

RESUMEN

BACKGROUND: The purpose of this study was to determine if hearts could be successfully reanimated after death in an extra corporeal circuit. METHODS: Reanimation of pig and dog heart was accomplished in an extra corporeal circuit after death by lethal injection of Pentothal (euthanasia). A total of 42 experiments were performed. RESULTS: The most successful combination included enhancement of the cardioplegic and reperfusion solutions with amino acids, calcium and magnesium ions, and using the animals own drug free blood in the reperfusion solution. Successful resuscitation of the heart was accomplished after ischemic cold storage as long as 9 hours after death. A beating heart was sustained by the extra corporeal circuit for over 10 hours (635 minutes). CONCLUSIONS: In summary, successfully reanimation of the heart in an extra corporeal circuit is possible when cold cardioplegic solution is administered 10-35 minutes after death by lethal injection of Pentothal.


Asunto(s)
Corazón/fisiopatología , Animales , Soluciones Cardiopléjicas , Muerte , Perros , Circulación Extracorporea , Técnicas In Vitro , Reperfusión Miocárdica , Resucitación , Porcinos
5.
Hepatology ; 27(2): 392-401, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9462636

RESUMEN

The CCAAT/enhancer binding protein alpha (C/EBP alpha) binds to specific promoter sequences and directs transcription of many genes expressed in the liver. Overexpression of C/EBP alpha in established cell lines inhibits cell proliferation. Primary hepatocytes from newborn C/EBP alpha(-/-) mice and normal littermates were used to determine whether the absence of C/EBP alpha increased proliferation and/or transformation of these cells in vitro. DNA synthesis, as measured by bromodeoxyuridine (BrdU) incorporation 24 hours postharvest, was fourfold higher in cells from C/EBP alpha(-/-) pups. Established cell lines were derived from 7 of 8 hepatocyte cultures initiated from null mutants, 4 of 23 cultures from heterozygotes, and 0 of 12 cultures from wild-type animals. C/EBP alpha(-/-) cultures had epithelial morphology, showed bile canaliculi, and expressed albumin messenger RNA (mRNA). When cultured on Matrigel, which promotes differentiation, cell lines derived from C/EBP alpha(-/-) mice formed cords and increased albumin mRNA expression by 1.7- to 3.8-fold. C/EBP alpha(-/-) cell lines exhibited rapid growth and rapid accumulation of chromosomal abnormalities, and were capable of forming nodules when inoculated into the abdominal subcutaneous tissue of nude mice. Our data show that C/EBP alpha is an important regulator of hepatocyte proliferation and participates in the maintenance of the nontransformed hepatic phenotype in vitro.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , ADN/biosíntesis , Hígado/metabolismo , Proteínas Nucleares/metabolismo , Adenocarcinoma/patología , Albúminas/metabolismo , Animales , Animales Recién Nacidos , Northern Blotting , Bromodesoxiuridina/farmacocinética , Proteínas Potenciadoras de Unión a CCAAT , Carcinoma Hepatocelular/patología , División Celular/fisiología , Línea Celular , Línea Celular Transformada/patología , Supervivencia Celular , Transformación Celular Neoplásica , Células Cultivadas , ADN/metabolismo , Proteínas de Unión al ADN/genética , Expresión Génica , Humanos , Cariotipificación , Hígado/citología , Hígado/patología , Hígado/ultraestructura , Neoplasias Hepáticas/patología , Ratones , Ratones Noqueados , Ratones Desnudos , Microscopía Electrónica , Trasplante de Neoplasias , Proteínas Nucleares/genética , ARN Mensajero/análisis , Tirosina Transaminasa/metabolismo
6.
Proc Natl Acad Sci U S A ; 94(2): 569-74, 1997 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-9012825

RESUMEN

Transcription factors are master regulatory switches of differentiation, including the development of specific hematopoietic lineages from stem cells. Here we show that mice with targeted disruption of the CCAAT enhancer binding protein alpha gene (C/EBP alpha) demonstrate a selective block in differentiation of neutrophils. Mature neutrophils and eosinophils are not observed in the blood or fetal liver of mutant animals, while other hematopoietic lineages, including monocytes, are not affected. Instead, most of the white cells in the peripheral blood of mutant mice had the appearance of myeloid blasts. We also observed a selective loss of expression of a critical gene target of CCAAT enhancer binding protein alpha, the granulocyte colony-stimulating factor receptor. As a result, multipotential myeloid progenitors from the mutant fetal liver are unable to respond to granulocyte colony-stimulating factor signaling, although they are capable of forming granulocyte-macrophage and macrophage colonies in methylcellulose in response to other growth factors. Finally, we demonstrate that the lack of granulocyte development results from a defect intrinsic to the hematopoietic system; transplanted fetal liver from mutant mice can reconstitute lymphoid but not neutrophilic cells in irradiated recipients. These studies suggest a model by which transcription factors can direct the differentiation of multipotential precursors through activation of expression of a specific growth factor receptor, allowing proliferation and differentiation in response to a specific extracellular signal. In addition, the c/ebp alpha -/- mice may be useful in understanding the mechanisms involved in acute myelogenous leukemia, in which a block in differentiation of myeloid precursors is a key feature of the disease.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Factor Estimulante de Colonias de Granulocitos/fisiología , Hematopoyesis , Neutrófilos/fisiología , Proteínas Nucleares/metabolismo , Receptores de Factor Estimulante de Colonias de Granulocito/genética , Animales , Proteínas Potenciadoras de Unión a CCAAT , Proteínas de Unión al ADN/fisiología , Regulación de la Expresión Génica , Hígado/embriología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas Nucleares/fisiología , ARN Mensajero/genética , Transducción de Señal
7.
Artif Organs ; 20(12): 1304-9, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8947453

RESUMEN

A device has been designed, constructed, and tested to provide pulsatile pressure/flow to a standard extracorporeal bypass circuit. The pulsatile augmentation device is pneumatically driven similar to an artificial heart ventricle except that there are no valves. It is constructed of polyurethane by vacuum forming and high frequency welding. Drivers used are a modified Arrow-Kontron intraaortic balloon pump or the Utah artificial heart driver. In vitro testing with fresh bovine blood demonstrated acceptable blood compatibility and hemodynamic function. In vivo testing for 4 h in a right and left heart extracorporeal bypass circuit showed good pulse augmentation in pulmonary and systemic bypass circuits. The device shows promise for adding pulse to standard cardiopulmonary bypass and to extracorporeal right heart circulatory assist circuits.


Asunto(s)
Puente Cardiopulmonar/normas , Circulación Extracorporea , Animales , Función Atrial , Materiales Biocompatibles/metabolismo , Bovinos , Hemodinámica/fisiología , Técnicas In Vitro , Poliuretanos/metabolismo , Flujo Pulsátil
8.
J Nutr ; 126(11): 2697-708, 1996 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8914939

RESUMEN

Modern genetics has developed methods to modify the expression of genes in animals to study the factors responsible for the tissue-specific expression and hormonal and dietary regulation of metabolic processes. As these methods are applied to genes that code for critical proteins in metabolic pathways, a new insight into the control of metabolism is emerging. There are three general approaches currently in use. First, is the introduction of genes into the germ line to create transgenic animal models in which the gene of interest is over-expressed. This model is of particular value for promoter analysis because it is possible to introduce specific mutations into a putative regulatory region of a transgene and study its transcriptional control in the intact animal. Second, the developmental function of a gene product and its effect on various metabolic processes in a mouse can be directly determined by deleting a gene of interest by homologous recombination. Gene "knockout" mice are currently available with deletions in the genes for a variety of transcription factors and other biologically active proteins, permitting a critical analysis of the proteins responsible for the metabolic patterning of the animal. Third, the metabolic role of a gene of interest in a specific tissue can be studied by ablating its mRNA by the introduction of a transgene that codes for antisense mRNA targeted against the gene transcript. Because it is possible to use a transgene with a tissue-specific promoter, this procedure allows the isolation of the metabolic effect to a selected tissue in the transgenic animal. Taken together, these procedures provide a unique set of metabolic models for an in-depth study of metabolic regulation. This review will present examples of selected animal models currently available and will outline the challenge these animals present for investigators in the nutritional sciences.


Asunto(s)
Metabolismo Energético/genética , Ratones Transgénicos/metabolismo , Modelos Biológicos , Animales , Secuencia de Bases , ADN/análisis , ADN/química , ADN/genética , Metabolismo Energético/fisiología , Eliminación de Gen , Regulación de la Expresión Génica , Hígado/fisiología , Ratones , Ratones Transgénicos/fisiología , Datos de Secuencia Molecular , Fosfoenolpiruvato Carboxiquinasa (ATP) , Fosfoenolpiruvato Carboxiquinasa (GTP)/genética , Fosfoenolpiruvato Carboxiquinasa (GTP)/fisiología , ARN Mensajero/análisis , ARN Mensajero/química , ARN Mensajero/genética , Factores de Transcripción/genética , Factores de Transcripción/fisiología , Transcripción Genética
9.
Science ; 269(5227): 1108-12, 1995 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-7652557

RESUMEN

Mice homozygous for the targeted deletion of the c/ebp alpha gene, which expresses the CCAAT/enhancer-binding protein alpha (C/EBP alpha), did not store hepatic glycogen and died from hypoglycemia within 8 hours after birth. In these mutant mice, the amounts of glycogen synthase messenger RNA were 50 to 70 percent of normal and the transcriptional induction of the genes for two gluconeogenic enzymes, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, was delayed. The hepatocytes and adipocytes of the mutant mice failed to accumulate lipid and the expression of the gene for uncoupling protein, the defining marker of brown adipose tissue, was reduced. This study demonstrates that C/EBP alpha is critical for the establishment and maintenance of energy homeostasis in neonates.


Asunto(s)
Proteínas de Unión al ADN/fisiología , Metabolismo Energético , Proteínas Nucleares/fisiología , Tejido Adiposo/metabolismo , Tejido Adiposo Pardo/metabolismo , Animales , Animales Recién Nacidos , Glucemia/metabolismo , Proteínas Potenciadoras de Unión a CCAAT , Proteínas Portadoras/genética , Proteínas de Unión al ADN/genética , Femenino , Regulación de la Expresión Génica , Glucosa-6-Fosfatasa/genética , Glucógeno Sintasa/genética , Glucógeno Sintasa/metabolismo , Homeostasis , Humanos , Canales Iónicos , Metabolismo de los Lípidos , Hígado/metabolismo , Glucógeno Hepático/metabolismo , Masculino , Proteínas de la Membrana/genética , Ratones , Ratones Noqueados , Proteínas Mitocondriales , Proteínas Nucleares/genética , Fosfoenolpiruvato Carboxiquinasa (GTP)/genética , ARN Mensajero/metabolismo , Albúmina Sérica/genética , Proteína Desacopladora 1
10.
Genomics ; 19(2): 291-7, 1994 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-8188259

RESUMEN

Structural alterations in human chromosome region 3p14-p23 resulting in the inactivation of one or more tumor suppressor genes are thought to play a pathogenic role in small cell lung cancer, renal cell carcinoma, and other human neoplasms. To identify putative tumor suppressor genes, 428 recombinant clones from a microdissection library specific for human chromosome region 3p14 were isolated and characterized. Ninety-six of these (22.5%) were human single-copy DNA sequences, 57 of which were unique sequence clones. Forty-four of these were mapped to the microdissected region using a cell hybrid mapping panel. Within this mapping panel, four probes detected two new chromosome breakpoints that were previously indistinguishable from the translocation breakpoint t(3;8) in 3p14.2 in hereditary renal cell carcinoma. One probe maps to the homozygously deleted region of the small cell lung cancer cell line U2020. In addition, microdissection clones have been shown to be suitable for isolation of yeast artificial chromosomes.


Asunto(s)
Cromosomas Humanos Par 3 , Biblioteca de Genes , Genes Supresores de Tumor , Neoplasias/genética , Animales , Células CHO , Carcinoma de Células Pequeñas/genética , Aberraciones Cromosómicas , Cromosomas Artificiales de Levadura , Clonación Molecular , Cricetinae , ADN/genética , Sondas de ADN , Humanos , Células Híbridas , Hibridación Fluorescente in Situ , Neoplasias Pulmonares/genética , Eliminación de Secuencia , Células Tumorales Cultivadas
11.
Ann Thorac Surg ; 56(2): 228-35; discussion 235-6, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8347003

RESUMEN

Replacement of the aortic valve with cryopreserved aortic allograft was performed in 88 patients during the period from July 1985 until January 1993. Age of patients ranged from 15 to 75 years (mean, 44 years). The cause of aortic valve disease was congenital in 39 (44%), rheumatic in 9 (10%), degenerative in 14 (16%), endocarditis in 11 (13%), and failed prosthesis in 15 (17%). The operation was performed by freehand allograft technique in 71 patients (81%). There were no perioperative deaths. Two patients died later at 4 months and 5 years after operation (actuarial survival = 94% at 7.5 years). Follow-up extending to 7.5 years shows 87% of patients are in New York Heart Association functional class I. No thromboembolism has been detected in any patient. Infection was cured in all patients with endocarditis. Mild aortic valve incompetence was detected by diastolic murmur in 45% of patients. Only three valves have been removed at reoperation: one was removed early for technical reasons, and two valves were removed for structural degeneration at 33 and 55 months; the latter was infected. Actuarial freedom from reoperation for any reason was 89%; for structural deterioration it was 93% at 7.5 years. Aortic valve replacement with cryopreserved aortic allograft can be safely performed in adult patients. Medium-term results show excellent freedom from thromboembolism and cure of bacterial endocarditis. Mild aortic valve incompetence is often present, but reoperation for progressive incompetence is unusual.


Asunto(s)
Válvula Aórtica/trasplante , Criopreservación , Análisis Actuarial , Adolescente , Adulto , Anciano , Válvula Aórtica/anomalías , Endocarditis Bacteriana/etiología , Endocarditis Bacteriana/cirugía , Femenino , Enfermedades de las Válvulas Cardíacas/mortalidad , Enfermedades de las Válvulas Cardíacas/cirugía , Humanos , Masculino , Métodos , Persona de Mediana Edad , Complicaciones Posoperatorias , Reoperación , Cardiopatía Reumática/cirugía , Factores de Riesgo , Tromboembolia/etiología
12.
Genomics ; 17(2): 341-7, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8406484

RESUMEN

The constitutive 3p14.2 fragile site is the most highly inducible fragile site in the human genome. This locus may predispose chromosome 3 to specific losses due to deletions and translocations that have been associated with several malignancies, including hereditary renal cell carcinoma. Using aphidicolin concentrations of 0.4 and 4.0 microM, we have generated and isolated 23 and 22 respective somatic cell hybrids that contain chromosome 3 short-arm breaks. The breakpoints in these hybrids have been localized with numerous chromosome 3 markers. We have observed that at the low aphidicolin dose, chromosome-3 breaks cluster within the 3p14.2 region, whereas at the high aphidicolin dose, two new loci, one within 3p14.1 and the other near the centromere, become predominantly affected. Our studies have failed to differentiate any of the 3p14.2 breakpoints from each other or from the t(3;8)(p14.2;q24.13) familial renal cell carcinoma translocation breakpoint, suggesting that the fragile site may have played a role in the generation of this balanced translocation. The resulting somatic cell hybrids generated from this work have refined the marker localizations within 3p13-p21.1 and should facilitate the physical characterization of this interesting region.


Asunto(s)
Afidicolina/toxicidad , Fragilidad Cromosómica , Cromosomas Humanos Par 3/efectos de los fármacos , Daño del ADN , Mutágenos/toxicidad , Animales , Southern Blotting , Sitios Frágiles del Cromosoma , Mapeo Cromosómico , Cricetinae , Cricetulus , ADN/genética , ADN/aislamiento & purificación , Humanos , Células Híbridas/efectos de los fármacos , Mutagénesis , Reacción en Cadena de la Polimerasa
13.
Cardiovasc Surg ; 1(3): 303-4, 1993 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8076050

RESUMEN

A case of aneurysm of the body of the left atrium is reported. Diagnosis of this condition should be considered in patients presenting with supraventricular tachyarrhythmia and a mass on the left side of the heart. Surgery to remove the aneurysm is the treatment of choice.


Asunto(s)
Aneurisma Cardíaco/cirugía , Atrios Cardíacos/cirugía , Adulto , Femenino , Aneurisma Cardíaco/congénito , Aneurisma Cardíaco/diagnóstico por imagen , Atrios Cardíacos/anomalías , Atrios Cardíacos/diagnóstico por imagen , Insuficiencia Cardíaca/diagnóstico por imagen , Insuficiencia Cardíaca/cirugía , Hemodinámica/fisiología , Humanos , Técnicas de Sutura , Tomografía Computarizada por Rayos X
14.
Genomics ; 14(4): 891-6, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1478670

RESUMEN

Using the human/hamster cell line UCTP2A-3, we have generated and isolated three hybrids, each containing a novel human chromosome 3p break. All chromosome 3 materials distal to the breaks were lost. Two of the breakpoints were produced using aphidicolin induction; the third breakpoint occurred spontaneously. The aphidicolin-induced breaks were localized to 3p21.1 in hybrid AR1 and to p14.1 in hybrid AR2. The spontaneous break was localized to 3p11 in hybrid 2A-3-1. These hybrids were used to sublocalize 18 chromosome 3 probes further to five regions within 3cen-p21.1. The new hybrids and sublocalized markers will be useful in the study and characterization of the 3p11, 3p14.1, and 3p21.1 segments of chromosome 3.


Asunto(s)
Cromosomas Humanos Par 3 , Animales , Afidicolina/toxicidad , Secuencia de Bases , Bandeo Cromosómico , Cricetinae , ADN , Marcadores Genéticos , Humanos , Células Híbridas , Cariotipificación , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa
15.
Genomics ; 11(1): 179-87, 1991 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1662664

RESUMEN

A total of 5700 human chromosome 3-specific cosmid clones was isolated from a series of cosmid libraries constructed from somatic cell hybrids whose only human component was an entire chromosome 3 or a chromosome 3 containing an interstitial deletion removing 50% of long arm sequences. Several unique sequence chromosome 3-specific hybridization probes were isolated from each of 616 of these cosmids. These probes were then used to localize the cosmids by hybridization to a somatic cell hybrid deletion mapping panel capable of resolving chromosome 3 into nine distinct subregions. All 616 of the cosmids were localized to either the long or short arm of chromosome 3 and 63% of the short arm cosmids were more precisely localized. We have identified a total of 87 cosmids that contain fragments that are evolutionarily conserved. Fragments from these cosmids should prove useful in the identification of new chromosome 3-specific genes as well as in comparative mapping studies. The localized cosmids should provide excellent saturation of human chromosome 3 and facilitate the construction of physical and genetic linkage maps to identify various disease loci including Von Hippel Lindau disease and renal and small cell lung carcinoma.


Asunto(s)
Cromosomas Humanos Par 3 , Animales , Células CHO , Bandeo Cromosómico , Deleción Cromosómica , Mapeo Cromosómico , Clonación Molecular , Cósmidos , Cricetinae , Sondas de ADN , Enzimas de Restricción del ADN/metabolismo , Biblioteca Genómica , Células HeLa , Humanos , Células Híbridas , Hibridación de Ácido Nucleico , Recombinación Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA